160 related articles for article (PubMed ID: 19052467)
1. Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients--a Japanese prospective eight-year study.
Takemoto F; Katori H; Sawa N; Hoshino J; Suwabe T; Nakanishi S; Arai S; Fukuda S; Kodaka K; Shimada M; Yamazaki C; Yokoyama K; Nakano Y; Funahashi T; Ubara Y; Yamada A; Takaichi K; Uchida S
Nephron Clin Pract; 2009; 111(1):c12-20. PubMed ID: 19052467
[TBL] [Abstract][Full Text] [Related]
2. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses.
Hashimoto N; Kanda J; Nakamura T; Horie A; Kurosawa H; Hashimoto T; Sato K; Kushida S; Suzuki M; Yano S; Iwai R; Takahashi H; Yoshida S
Metabolism; 2006 Dec; 55(12):1653-7. PubMed ID: 17142139
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
Rothenbacher D; Brenner H; März W; Koenig W
Eur Heart J; 2005 Aug; 26(16):1640-6. PubMed ID: 15932907
[TBL] [Abstract][Full Text] [Related]
4. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease.
Inoue T; Kotooka N; Morooka T; Komoda H; Uchida T; Aso Y; Inukai T; Okuno T; Node K
Am J Cardiol; 2007 Aug; 100(4):569-74. PubMed ID: 17697807
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and coronary heart disease: a prospective study and meta-analysis.
Sattar N; Wannamethee G; Sarwar N; Tchernova J; Cherry L; Wallace AM; Danesh J; Whincup PH
Circulation; 2006 Aug; 114(7):623-9. PubMed ID: 16894037
[TBL] [Abstract][Full Text] [Related]
6. Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up study.
Khalili P; Flyvbjerg A; Frystyk J; Lundin F; Jendle J; Engström G; Nilsson PM
Diabetes Metab; 2010 Apr; 36(2):137-43. PubMed ID: 20153676
[TBL] [Abstract][Full Text] [Related]
7. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
[TBL] [Abstract][Full Text] [Related]
8. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
[TBL] [Abstract][Full Text] [Related]
9. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany.
Koenig W; Khuseyinova N; Baumert J; Meisinger C; Löwel H
J Am Coll Cardiol; 2006 Oct; 48(7):1369-77. PubMed ID: 17010797
[TBL] [Abstract][Full Text] [Related]
11. Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin.
Nishida H; Horio T; Suzuki Y; Iwashima Y; Kamide K; Kangawa K; Kawano Y
Peptides; 2008 Apr; 29(4):599-605. PubMed ID: 18222566
[TBL] [Abstract][Full Text] [Related]
12. Gender-related differences in the relationship between plasma homocysteine, anthropometric and conventional biochemical coronary heart disease risk factors in middle-aged Indians.
Pitla S; Nagalla B
Ann Nutr Metab; 2009; 54(1):1-6. PubMed ID: 19194102
[TBL] [Abstract][Full Text] [Related]
13. Plasma adiponectin is associated with ankle-brachial index in patients on haemodialysis.
Lim PS; Hu CY; Wu MY; Wu TK; Chang HC
Nephrology (Carlton); 2007 Dec; 12(6):546-52. PubMed ID: 17995579
[TBL] [Abstract][Full Text] [Related]
14. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.
Schnabel R; Messow CM; Lubos E; Espinola-Klein C; Rupprecht HJ; Bickel C; Sinning C; Tzikas S; Keller T; Genth-Zotz S; Lackner KJ; Münzel TF; Blankenberg S
Eur Heart J; 2008 Mar; 29(5):649-57. PubMed ID: 18263867
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women.
Pischon T; Pai JK; Manson JE; Hu FB; Rexrode KM; Hunter D; Rimm EB
Obesity (Silver Spring); 2007 Aug; 15(8):2051-60. PubMed ID: 17712123
[TBL] [Abstract][Full Text] [Related]
16. Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemodialysis patients.
Nishimura M; Hashimoto T; Kobayashi H; Yamazaki S; Okino K; Fujita H; Inoue N; Takahashi H; Ono T
Nephrol Dial Transplant; 2006 Jun; 21(6):1640-7. PubMed ID: 16431887
[TBL] [Abstract][Full Text] [Related]
17. Erectile dysfunction predicts coronary heart disease in type 2 diabetes.
Ma RC; So WY; Yang X; Yu LW; Kong AP; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
J Am Coll Cardiol; 2008 May; 51(21):2045-50. PubMed ID: 18498959
[TBL] [Abstract][Full Text] [Related]
18. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
19. Serum dehydroepiandrosterone sulfate levels predict longevity in men: 27-year follow-up study in a community-based cohort (Tanushimaru study).
Enomoto M; Adachi H; Fukami A; Furuki K; Satoh A; Otsuka M; Kumagae S; Nanjo Y; Shigetoh Y; Imaizumi T
J Am Geriatr Soc; 2008 Jun; 56(6):994-8. PubMed ID: 18422949
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of fasting plasma glucose to predict mortality or coronary heart disease in persons > or = 60 years of age without diabetes mellitus or in those with undiagnosed diabetes mellitus (from The Dubbo Study).
Simons LA; Simons J; Friedlander Y; McCallum J
Am J Cardiol; 2008 Oct; 102(7):831-4. PubMed ID: 18805106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
